“Doctor, You Should Visit This Ayurvedic Healer—He Cures Cancer!” 🤡🎗️ Ah, another day in the life of an oncologist! A random patient attender walks in, sits down, and with absolute conviction tells me about a “famous village healer” who cures cancer with herbs, coconut water,

The more complex the Ayurvedic herbal product is, the higher chance that it can actually harm the consumer. Multiple herbal components are the biggest risk factor for herb-induced liver injury as per ours and others published scientific work. This product also contains well known

Can we get away without breast surgery in the future? 50 patients (cT1-2, N0-1, Her2+ve or TNBC) who had residual breast tumour of less than 2cm and a negative biopsy post NACT ➡️ breast surgery was omitted. With a follow up of 55months ipsilateral breast tumour recc was 0%

Today is World Health Day – a timely reminder that health is our greatest asset. As a medical oncologist, I witness every day how unpredictable life can be when health takes a backseat. While modern medicine has come a long way, prevention still remains the best cure.

Secondary malignancy risk after testicular GCT treatment 21 trials, 88,863 pts, mFU: 12.5y No ⬆️ risk with surgery alone ⬆️ risk with RT (1.66), chemo (1.65), or both (2.73) 💥Important to keep in mind when deciding treatment in stage 1 JNCI academic.oup.com/jnci/advance-a…

Now a randomized trial of Afatinib vs Chemotherapy in NSCLC With Uncommon Activating EGFR Mutations 👉Exclusions: T790M; Exon 20 insertions 👉 mPFS 10.6 vs 5.7mo favoring AFATINIB 👉ORR 62% vs 56% favouring AFATINIB Stephen V Liu, MD Nirmal Raut OncoAlert ascopost.com/news/may-2025/…

🚨First oral FDA approval for pheochromocytoma and paraganglioma 💊Belzutifan 👉ORR: 26% 👉DOR: 20months 👉30% patients had reduction in atleast one anti-hypertensive meds OncoAlert FDA Oncology #MedX ascopost.com/news/may-2025/…

ctDNA informed treatment escalation in stage III colon cancer DIDNOT result in improvement in RFS. 👉ctDNA is colon cancer prognostic but yet not PREDICTIVE?👈 OncoAlert #MedX The ASCO Post meetings.asco.org/abstracts-pres…

Dr. Saadvik Raghuram y Stephen V Liu, MD Nirmal Raut OncoAlert We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing. oncodaily.com/science/afatin…

FDA Approves Neoadjuvant and Adjuvant Pembrolizumab for Resectable, Locally Advanced Head and Neck Cancer For patients whose tumors expressed PD-L1 CPS ≥ 1, EFS improved with Pembro➡️ 38 vs 29mo (HR 0.70) OncoAlert Nirmal Raut Dr Amol Akhade ascopost.com/news/june-2025…

Preexisting cardiovascular disease did not confer an increased risk of cardiotoxicity compared with the overall study population with 5FU based chemo for GI malignancies. ascopost.com/news/june-2025…

mHSPC patients who have alterations in HRR tend to have➡️ 1️⃣ Shorter time to castrate resistance. 2️⃣ Inferior OS A poor prognostic marker. First real world evidence study. OncoAlert #MedX aacrjournals.org/clincancerres/…

🚨FDA approves Talectrectinib for ROS1 positive locally advanced or metastatic NSCLC. ➡️ Response rates in TKI naive (85-90%) ➡️ ORR in patients with prior TKI (52%) ➡️ CNS response rates in TKI Naive (73%), prior TKI (63%) ➡️ Watch out for Dizziness, QTc OncoAlert Dr Amol Akhade

Dr. Saadvik Raghuram y OncoAlert Dr Amol Akhade We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing. oncodaily.com/insight/talect…

Tarlatamab shows OS benefit in 2nd line setting of advanced SCLC. 1. Tarlatamab is a bispecific T cell engager that targets DLL3 and CD3 T cell. 2. DLL3 present on surface of 85-96% SCLC 3. OS improved from 8.3mo to 13.6 with Tarlatamab compared to chemo 4.mPFS also slightly

Late-night scrolling = more than just lost sleep. It disrupts circadian rhythm, weakens immunity & may raise cancer risk. Insights from me on this blog - drsaadvikraghuram.com/blog/how-late-… #CancerAwareness #SleepHealth #Oncology

Practice-changing study in hematology! Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial Out in Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Tweet 1: 🚨 New on TV9 English: “Smoker’s lung” is rising among non-smokers, and it’s not just about smoking history. We must look closer at environmental exposures. Read my full article below.  tv9english.com/lifestyle/expl…

September is Childhood Cancer Awareness Month—a time to spotlight the signs every parent should know. From persistent fever to unexplained bruising, early detection changes outcomes. Learn the lifesaving SILUAN checklist and why timely action matters. drsaadvikraghuram.com/blog/childhood…

In India, many breast cancers are detected late. We must change that. My blog shares how Hyderabad women can lead the way. drsaadvikraghuram.com/blog/october-b… #BreastCancerAwareness #Hyderabad #WomenHealth